Condition
Chronic Myeloid Leukemia (CML) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Chronic Myeloid Leukemia (CML) clinical trials that are recruiting, at sites in 4 countries (most in France (3), Italy (1), United States (1)). By phase: Phase 2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Chronic Myeloid Leukemia (CML) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Asciminib for chronic phase CML with T315I mutation | Phase 2 | Aachen and 9 other locations | Recruiting | Aug 27, 2026 |
| Early Tacrolimus Taper After Allogeneic Transplant | Phase 1 | Palo Alto, California | Recruiting | Dec 24, 2025 |
| Care organization and quality of life for people with chronic myeloid leukemia in the Lombardy hematology network | — | Monza, MB | Recruiting | Sep 10, 2025 |
| Using asciminib to treat chronic myeloid leukemia patients with a specific mutation | Phase 2 | Bordeaux and 5 other locations | Recruiting | Jul 23, 2024 |
| Real-life data collection for patients with Chronic Myeloid Leukemia | — | Annecy and 13 other locations | Recruiting | Jul 27, 2023 |
| Second STOP After Pioglitazone Priming in CML Patients | Phase 2 | Le Chesnay and 5 other locations | Recruiting | Sep 5, 2016 |
All recruiting trials (6)
-
Asciminib for chronic phase CML with T315I mutation
This study tests asciminib 200 mg twice daily in adults with chronic phase CML and a T315I mutation after stem cell transplant to see if it helps control leukemia.
-
Early Tacrolimus Taper After Allogeneic Transplant
This study tests whether stopping tacrolimus early after an allogeneic stem cell transplant is safe and feasible for people with AML, MDS, MF, CML, CMML, or GVHD risk after transplant.
-
Care organization and quality of life for people with chronic myeloid leukemia in the Lombardy hematology network
This project will see if the way hematology centers are organized affects quality of life for adults with chronic myeloid leukemia in Lombardy.
-
Using asciminib to treat chronic myeloid leukemia patients with a specific mutation
This study is testing if a new drug called asciminib can help people with chronic myeloid leukemia who have a specific mutation and haven't had success with other treatments.
-
Real-life data collection for patients with Chronic Myeloid Leukemia
This study is collecting information from people with Chronic Myeloid Leukemia to see how different treatments work and how they affect patients over time.
-
Second STOP After Pioglitazone Priming in CML Patients
This phase 2 study tests whether adding pioglitazone to a TKI can help CML patients who lost major molecular response after stopping a TKI to regain disease control.
Related topics
Quick answers
How many Chronic Myeloid Leukemia (CML) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in France (3 trials), Italy (1 trial), United States (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.